Evidence-Based Guidelines: Optimizing Imaging in Cancer Care

Restricted access

Dr. Pamela DiPiro is an Institute Physician at Dana-Farber Cancer Institute (DFCI), Associate Radiologist at Brigham and Women's Hospital, and Assistant Professor of Radiology at Harvard Medical School. She is a fellowship-trained breast imager and oncologic radiologist with 23 years of experience on the faculty at Harvard Medical School, and a member of the imaging departments at DFCI and Brigham and Women's Hospital. She has served as Clinical Director of CT at DFCI since 2000. Her chief research interests are in oncologic imaging and the roles that various imaging modalities play in evaluating specific clinical situations, as well as the active role radiologists play in patient care.

The ideas and viewpoints expressed in this commentary are those of the author and do not necessarily represent any policy, position, or program of NCCN.

  • 1.

    Hillman BJ, Goldsmith JC. The uncritical use of high-tech medical imaging. N Engl J Med 2010;363:46.

  • 2.

    Puglisi F, Follador A, Minisini AM. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol Off J Eur Soc Med Oncol 2005;16:263266.

    • Search Google Scholar
    • Export Citation
  • 3.

    Kim H, Han W, Moon HG. The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma. Breast Cancer Res Treat 2011;126:637641.

    • Search Google Scholar
    • Export Citation
  • 4.

    NCCN Imaging Appropriate Use Criteria. Available at: https://www.nccn.org/professionals/imaging/default.aspx. Accessed May 3, 2017.

  • 5.

    Moy L, Newell MS, Mahoney MC. ACR appropriateness criteria stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. J Am Coll Radiol 2016;13(Suppl 11):e4352.

    • Search Google Scholar
    • Export Citation
  • 6.

    Schnipper LE, Smith TJ, Raghavan D. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 2012;30:17151724.

    • Search Google Scholar
    • Export Citation
  • 7.

    Shinagare AB, Ip IK, Lacson R. Gastrointestinal stromal tumor: optimizing the use of cross-sectional chest imaging during follow-up. Radiology 2015;274:395404.

    • Search Google Scholar
    • Export Citation
  • 8.

    Shinagare AB, Suh CH, Kim KW. Ovarian cancer: an evidence-based, easy-to-use prediction rule to optimize the use of follow-up chest CT. J Am Coll Radiol 2017;14:499508.

    • Search Google Scholar
    • Export Citation
  • 9.

    O'Connor SD, Sodickson AD, Ip IK. Journal club: requiring clinical justification to override repeat imaging decision support: impact on CT use. AJR Am J Roentgenol 2014;203:W482490.

    • Search Google Scholar
    • Export Citation
  • 10.

    Giardino A, Gupta S, Olson E. Role of imaging in the era of precision medicine. Acad Radiol 2017;24:639649.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 122 86 3
PDF Downloads 31 28 2
EPUB Downloads 0 0 0